BMYMP Stock: Bristol-Myers Squibb Company PFD CONV 2 Stock Price, Analysis & Insights
Get live BMYMP stock price $400.00, comprehensive Bristol-Myers Squibb Company PFD CONV 2 stock analysis, charts, news, and expert forecast. Real-time BMYMP stock data and investment insights.
Loading chart data...
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) Overview
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, BMYMP trades at $400.00 with a market capitalization of 814.59B . Over the past 52 weeks, BMYMP has traded between $400.00 and $1050.00 , with the current price positioned at approximately 0% of ...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 814.59B
- Current price: $400.00
- 52-week range: $400.00 - $1050.00
- P/E ratio: 1777.78
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Bristol-Myers Squibb is a pharmaceutical company dedicated to the research, development, and commercialization of treatments for a wide array of medical conditions. Its primary therapeutic domains include cardiovascular health, oncology, and immunolo...
Company Information
- CEO
- Christopher S. Boerner
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 34100
Contact Information
- Website
- http://www.bms.com
- Address
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 814.6 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 1777.8)
✓ Lower volatility stock (Beta: 0.27) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Bristol-Myers Squibb Company PFD CONV 2 shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Bristol-Myers Squibb Company PFD CONV 2
- ⚠Investors should consider how Bristol-Myers Squibb Company PFD CONV 2 fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 1777.8) requires strong growth to justify
Market Cap
814.59B
P/E Ratio (TTM)
1777.78
Beta
0.27
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare BMYMP with peer companies:
- Price
- $189.90+0.00% (1D)
- Market cap
- 294.40B
- Price
- $10.16-0.29% (1D)
- Market cap
- 39.93B
- Price
- $46.74+1.89% (1D)
- Market cap
- 76.91B
- Price
- $23.32+2.33% (1D)
- Market cap
- 76.76B
- Price
- $25.12+1.84% (1D)
- Market cap
- 100.73B
- Price
- $144.88+0.00% (1D)
- Market cap
- 276.44B
- Price
- $414.00+1.22% (1D)
- Market cap
- 329.54B
- Price
- $50.42+0.56% (1D)
- Market cap
- 324.75B
- Price
- $411.25+0.00% (1D)
- Market cap
- 327.35B
- Price
- $86.67+0.00% (1D)
- Market cap
- 104.19B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
60/100 ⭐⭐⭐⭐
- Overall
- -1.4%
- NYSE
- -0.6%
- NASDAQ
- -2.2%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.2% | +1.6% | +1.7% | 19.1 | 100/100⭐⭐⭐⭐⭐ |
| Communication Services | -0.2% | -1.8% | +1.2% | 21.9 | 83/100⭐⭐⭐⭐⭐ |
| Energy | -0.2% | -6.1% | +1.5% | 37.0 | 75/100⭐⭐⭐⭐⭐ |
| Healthcare | -1.4% | -3.7% | -0.5% | 30.2 | 60/100⭐⭐⭐⭐ |
| Technology | -0.8% | -7.7% | +0.0% | 48.7 | 55/100⭐⭐⭐⭐ |
| Consumer Defensive | +0.7% | +3.0% | -1.6% | 31.1 | 50/100⭐⭐⭐ |
| Real Estate | -1.0% | -1.8% | -1.9% | 50.3 | 31/100⭐⭐ |
| Industrials | -2.7% | -7.6% | -2.1% | 41.5 | 30/100⭐⭐ |
| Basic Materials | -1.9% | -6.0% | -3.5% | 26.6 | 28/100⭐⭐ |
| Utilities | -2.1% | -6.9% | -8.5% | 25.3 | 24/100⭐ |
| Consumer Cyclical | -1.5% | -4.5% | -3.4% | 52.2 | 14/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score: 70% 1M momentum percentile + 30% valuation percentile (lower P/E ranks higher), shown as 0–100 with stars. Data as of 2026-06-11.